The American Board of Medical Specialties (ABMS) strongly disagrees with the persistent and misleading assertions that the National Board of Physicians and Surgeons (NBPAS) recertification process provides a means of continuing ABMS board certification or is equivalent to ABMS board certification. Claims of equivalence to ABMS certification or that NBPAS is a means to maintain […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-08-02 20:43:572022-08-02 20:43:57ABMS Response to National Board of Physicians and Surgeons’ Assertion of Certifying Body Equivalency
The Virginia Department of Health (VDH) is happy to inform you that the Monkeypox Treatment webpage for healthcare providers is now LIVE, and can be accessed here. This website provides information regarding the currently available treatment, Tecovirimat (TPOXX), and includes CDC guidance and requirements for patient eligibility, precautions to consider, and how to request TPOXX […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-07-28 15:48:592023-01-13 16:29:17VDH Monkeypox Treatment Webpage is Live
Presented by the American Medical Association in collaboration with the AMA Accelerating Change in Medical Education Consortium, the AMA Health Systems Science Scholars Program focuses on the implementation of health systems science curricula in undergraduate and graduate medical education. Apply now! The program will provide an overview of how to design, implement and evaluate health […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-07-28 15:45:342022-07-28 15:45:34Last chance to apply: Health Systems Science Scholars Program
Private Practice Playbook This new, free the AMA STEPS Forward® resource is full of information to help physicians determine if opening a private practice is the right move for them, including guidelines for running a private practice and strategies to help grow a practice into a successful healthcare facility. LEARN MORE and then DOWNLOAD THE […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-07-22 20:54:352022-07-22 20:55:04New Resources from the AMA
The FDA issued an emergency use authorization (EUA) for PAXLOVID (nirmatrelvir co-packaged with ritonavir) for the treatment of mild-to-moderate COVID-19 in certain adults and pediatric patients at high risk for progression to severe COVID-19, including hospitalization or death. On July 6, the FDA revised the EUA to let pharmacists prescribe and dispense PAXLOVID to eligible patients without seeing a doctor […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-07-14 16:47:102022-07-14 16:47:10COVID-19: FDA Authorizes Pharmacists to Prescribe PAXLOVID with Certain Limits
This week Secretary Becerra sent a letter to all hospitals and healthcare providers reminding them of their obligation to comply with EMTALA. The Secretary’s letter clarifies that EMTALA requirements preempt any state laws that restrict access to stabilizing medical treatment, including abortion procedures and other treatments that may result in the termination of a pregnancy. […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-07-13 19:04:272022-07-13 19:04:27AMA Update: Department of Health and Human Services (HHS) Enforcement of the Emergency Medical Treatment and Active Labor Act (EMTALA)
On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule for the 2023 Medicare physician payment schedule. While American Medical Association (AMA) staff will analyze and develop a summary of the 2,000+ page proposal, they wanted to make physicians aware of three key issues. Notably, the 2023 Medicare conversion […]
ABMS Response to National Board of Physicians and Surgeons’ Assertion of Certifying Body Equivalency
The American Board of Medical Specialties (ABMS) strongly disagrees with the persistent and misleading assertions that the National Board of Physicians and Surgeons (NBPAS) recertification process provides a means of continuing ABMS board certification or is equivalent to ABMS board certification. Claims of equivalence to ABMS certification or that NBPAS is a means to maintain […]
VDH Monkeypox Treatment Webpage is Live
The Virginia Department of Health (VDH) is happy to inform you that the Monkeypox Treatment webpage for healthcare providers is now LIVE, and can be accessed here. This website provides information regarding the currently available treatment, Tecovirimat (TPOXX), and includes CDC guidance and requirements for patient eligibility, precautions to consider, and how to request TPOXX […]
Last chance to apply: Health Systems Science Scholars Program
Presented by the American Medical Association in collaboration with the AMA Accelerating Change in Medical Education Consortium, the AMA Health Systems Science Scholars Program focuses on the implementation of health systems science curricula in undergraduate and graduate medical education. Apply now! The program will provide an overview of how to design, implement and evaluate health […]
New Resources from the AMA
Private Practice Playbook This new, free the AMA STEPS Forward® resource is full of information to help physicians determine if opening a private practice is the right move for them, including guidelines for running a private practice and strategies to help grow a practice into a successful healthcare facility. LEARN MORE and then DOWNLOAD THE […]
COVID-19: FDA Authorizes Pharmacists to Prescribe PAXLOVID with Certain Limits
The FDA issued an emergency use authorization (EUA) for PAXLOVID (nirmatrelvir co-packaged with ritonavir) for the treatment of mild-to-moderate COVID-19 in certain adults and pediatric patients at high risk for progression to severe COVID-19, including hospitalization or death. On July 6, the FDA revised the EUA to let pharmacists prescribe and dispense PAXLOVID to eligible patients without seeing a doctor […]
AMA Update: Department of Health and Human Services (HHS) Enforcement of the Emergency Medical Treatment and Active Labor Act (EMTALA)
This week Secretary Becerra sent a letter to all hospitals and healthcare providers reminding them of their obligation to comply with EMTALA. The Secretary’s letter clarifies that EMTALA requirements preempt any state laws that restrict access to stabilizing medical treatment, including abortion procedures and other treatments that may result in the termination of a pregnancy. […]
Proposed Physician Payment Schedule Rule
On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule for the 2023 Medicare physician payment schedule. While American Medical Association (AMA) staff will analyze and develop a summary of the 2,000+ page proposal, they wanted to make physicians aware of three key issues. Notably, the 2023 Medicare conversion […]